SCHEMBL8765949

SCHEMBL8765949

NS(=O)(=O)c1ccc(-c2c(-c3ccc([N+](=O)[O-])cc3)c(C(F)F)nn2-c2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 10/20 0.50
PTGS1 P23219 7/20 0.48
CA9 Q16790 6/20 0.47
CA2 P00918 5/20 0.47
CA1 P00915 4/20 0.47
CA12 O43570 4/20 0.47
CA14 Q9ULX7 3/20 0.47
CA3 P07451 1/20 0.44
CA4 P22748 1/20 0.44
CA6 P23280 1/20 0.44
CA5A P35218 1/20 0.44
CA7 P43166 1/20 0.44
CA13 Q8N1Q1 1/20 0.44
CA5B Q9Y2D0 1/20 0.44
NPC1 O15118 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
NFKB1 P19838 1/20 0.43
RAB9A P51151 1/20 0.43
NFKB2 Q00653 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8766023 0.97 PTGS2 (0.53) PTGS2PTGS1CA9CA2CA1
SCHEMBL8765554 0.95 PTGS2 (0.55) PTGS2PTGS1CA9CA2CA1
SCHEMBL8765086 0.90 PTGS2 (0.54) PTGS2PTGS1CA9CA2CA1
SCHEMBL8765432 0.90 PTGS2 (0.47) PTGS2NPC1ALDH1A1MAPTNFKB1
SCHEMBL8637420 0.87 PTGS2 (0.60) PTGS2PTGS1CA9CA2CA1
SCHEMBL8764778 0.87 PTGS2 (0.48) PTGS2PTGS1CA9CA2CA1
SCHEMBL27459433 0.87 PTGS2 (0.58) PTGS2PTGS1CA9CA2CA1
SCHEMBL8764581 0.87 PTGS2 (0.49) PTGS2PTGS1NPC1ALDH1A1MAPT
SCHEMBL8765225 0.86 PTGS2 (0.54) PTGS2PTGS1CA9CA2CA1
SCHEMBL8765642 0.86 PTGS2 (0.51) PTGS2PTGS1CA9CA2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0731794-B1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS SEARLE & CO (US) 1997-08-06 EP disclosed
US-5639777-A 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders G.D. SEARLE & CO. (US) 1997-06-17 US disclosed
EP-0731794-A1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS SEARLE & CO (US) 1996-09-18 EP disclosed
WO-1995015317-A1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS G.D. SEARLE & CO. (US) 1995-06-08 WO disclosed